Adverse effects of biologics: a network meta-analysis and Cochrane overview

Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara Maxwell, John K Macdonald, Graziella Filippini, Nicole Skoetz, Damian Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Michael Pt Lunn, Peter Tugwell, Rachelle Buchbinder

859 Citationer (Scopus)

Abstract

Biologics are used for the treatment of rheumatoid arthritis and many other conditions. While the efficacy of biologics has been established, there is uncertainty regarding the adverse effects of this treatment. Since serious risks such as tuberculosis (TB) reactivation, serious infections, and lymphomas may be common to the biologics but occur in small numbers across the various indications, we planned to combine the results from biologics used in many conditions to obtain the much needed risk estimates.
OriginalsprogEngelsk
TidsskriftCochrane Database of Systematic Reviews
Udgave nummer2
Sider (fra-til)CD008794
ISSN1469-493X
DOI
StatusUdgivet - 1 jan. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Adverse effects of biologics: a network meta-analysis and Cochrane overview'. Sammen danner de et unikt fingeraftryk.

Citationsformater